Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Oncology Letters|August 22, 2018
Role of PLK1 signaling pathway genes in gastrointestinal stromal tumorsJen-Shi Chen, Chun-Nan Yeh, Chi-Tung Cheng, et al.
Oncotarget|December 5, 2014
AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosisChien-Feng Li, Li-Tzong Chen, Jui Lan, et al.
Journal of Clinical Medicine|September 11, 2019
Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival ImpactKeng-Hao Liu, Chia-Yen Hung, Shu-Wen Hsueh, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2022
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 studyLi-Yuan Bai, Chung-Pin Li, Yan-Shen Shan, et al.
Biomedical Journal|January 3, 2024
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendationYung-Yeh Su, Nai-Jung Chiang, Tai-Jan Chiu, et al.
Oncotargets and Therapy|August 8, 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinomaChi-Tung Cheng, Yin-Yi Chu, Chun-Nan Yeh, et al.
Anticancer Research|September 10, 2014
Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patientsChih-Chieh Hsu, Chiao-En Wu, Jen-Shi Chen, et al.
British Journal of Cancer|July 2, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trialChia-Jui Yen, Ming-Huang Chen, Yen-Yang Chen, et al.
Thescientificworldjournal|June 27, 2014
Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinomaMing-Chun Ma, Yen-Yang Chen, Shau-Hsuan Li, et al.
American Journal of Cancer Research|December 12, 2022
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinomaNai-Jung Chiang, Yan-Shen Shan, Chung-Pin Li, et al.
Pageof 10